Standout Papers

MAFLD: How is it different from NAFLD? 2022 2026 2023 2024202
  1. MAFLD: How is it different from NAFLD? (2022)
    Cameron Gofton, Ming‐Hua Zheng et al. Clinical and Molecular Hepatology

Immediate Impact

13 standout
Sub-graph 1 of 5

Citing Papers

Current status and future trends of the global burden of MASLD
2024 Standout
Epidemiology of metabolic dysfunction-associated steatotic liver disease
2024 Standout
2 intermediate papers

Works of Cameron Gofton being referenced

MAFLD: an optimal framework for understanding liver cancer phenotypes
2023
MAFLD: How is it different from NAFLD?
2022 Standout

Author Peers

Author Last Decade Papers Cites
Cameron Gofton 206 66 31 109 9 251
Jacob George 219 85 30 102 14 272
Wanqing Liu 210 54 41 100 5 290
Valentina Peta 215 85 31 79 17 262
CP Day 159 62 33 60 7 224
Claudia La Mantia 210 114 21 82 16 265
Dennis Schrijnders 131 67 19 60 10 232
Yaron Arbel 174 67 17 52 8 269
Katherine Eberly 240 128 34 88 9 283
Heejoon Jang 180 110 61 95 16 247
Helene Gellert‐Kristensen 221 89 35 113 7 254

All Works

Loading papers...

Rankless by CCL
2026